Polymorphisms and overexpression of immune checkpoints PD-1, PD-L1, and CTLA-4 in DLBCL: biomarker insights from a case–control study

Clinical & Translational Oncology 2026

View at publisher

Authors: Habibe Sema Arslan, Ozan Salim, Ünal Ataş, Şule Darbaş, Nurten Sayin Ekinci, Yahya Kilinc, Fahri Uçar

DOI: 10.1007/s12094-026-04283-y

Cited by: 0

References: 25

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology

References 25